無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

細胞療法の世界市場:利用目的(臨床、研究)、種類(幹細胞、非幹細胞)、治療タイプ(自家移植、同種移植)別 - 市場規模、シェア、市場動向の分析 2018年〜2025年

Cell Therapy Market Size, Share, & Trends Analysis Report By Use (Clinical, Research), By Type (Stem & Non-stem Cells) By Therapy Type (Autologous, Allogenic), By Region, And Segment Forecasts, 2018 - 2025

発行 Grand View Research, Inc. 商品コード 748450
出版日 ページ情報 英文 120 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
細胞療法の世界市場:利用目的(臨床、研究)、種類(幹細胞、非幹細胞)、治療タイプ(自家移植、同種移植)別 - 市場規模、シェア、市場動向の分析 2018年〜2025年 Cell Therapy Market Size, Share, & Trends Analysis Report By Use (Clinical, Research), By Type (Stem & Non-stem Cells) By Therapy Type (Autologous, Allogenic), By Region, And Segment Forecasts, 2018 - 2025
出版日: 2018年11月05日 ページ情報: 英文 120 Pages
概要

世界の細胞療法市場は、2018年から2025年にかけて5.34%のCAGRで推移し、2025年までに79億2,000万米ドル規模の市場に成長することが予測されています。遺伝子、細胞、組織を応用した先進的医療品の開発に対する世界的な関心の高まりによって当市場の成長が促進されています。

当レポートでは、世界の細胞療法市場を調査し、市場の概要、利用目的・種類・治療タイプ・地域別の市場規模の推移と予測、市場動向、市場の成長要因および阻害要因の分析、ファイブフォース分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場のスナップショット

第2章 調査方法

  • 情報調達
  • 情報分析
  • 市場の構成と検証
  • 市場予測

第3章 市場変数、市場動向、範囲

  • 市場区分と範囲
  • 成長の見通しマッピング
  • SWOT分析
  • ファイブフォース分析

第4章 幹細胞/非幹細胞療法市場の分析と予測:利用目的別

  • 市場動向の分析:利用目的別
  • 臨床
  • 研究

第5章 幹細胞/非幹細胞療法市場の分析と予測:移植タイプ別

  • 市場動向の分析:移植タイプ別
  • 同種移植
  • 自家移植

第6章 幹細胞/非幹細胞療法市場の分析と予測:地域別

  • 市場シェアの分析:地域別
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ地域

第7章 競合情勢

  • 戦略のフレームワーク
  • 企業プロファイル
    • Kolon TissueGene, Inc.
    • MEDIPOST
    • Osiris Therapeutics, Inc.
    • Stemedica Cell Technologies, Inc.
    • Cells for Cells
    • NuVasive, Inc
    • Fibrocell Science, Inc.
    • Vericel Corporation
    • PHARMICELL Co., Ltd
    • ANTEROGEN.CO.,LTD
    • Celgene Corporation
図表

List of Tables

  • TABLE 1 Characteristics of 1,052 registered stem cell clinical trials and 286 trials that published primary outcome data in 333 publications with respect to status, phase, graft type, cell type, country, & funding, May 2017
  • TABLE 2 Some regenerative medicine FDA-approved products
  • TABLE 3 North America stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 4 North America stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 5 North America stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 6 North America stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 7 North America stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 8 U.S. stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 9 U.S. stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 10 U.S. stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 11 U.S. stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 12 U.S. stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 13 Canada stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 14 Canada stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 15 Canada stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 16 Canada stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 17 Canada stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 18 Europe stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 19 Europe stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 20 Europe stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 21 Europe stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 22 Europe stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 23 Germany stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 24 Germany stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 25 Germany stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 26 Germany stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 27 Germany stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 28 UK stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 29 UK stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 30 UK stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 31 UK stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 32 UK stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 33 Asia Pacific stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 34 Asia Pacific stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 35 Asia Pacific stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 36 Asia Pacific stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 37 Asia Pacific stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 38 Japan stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 39 Japan stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 40 Japan stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 41 Japan stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 42 Japan stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 43 China stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 44 China stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 45 China stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 46 China stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 47 China stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 48 Latin America stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 49 Latin America stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 50 Latin America stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 51 Latin America stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 52 Latin America stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 53 Brazil stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 54 Brazil stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 55 Brazil stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 56 Brazil stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 57 Brazil stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 58 MEA stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 59 MEA stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 60 MEA stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 61 MEA stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 62 MEA stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)
  • TABLE 63 South Africa stem cell & non-stem cell market estimates & forecasts, by use-type, 2014 - 2025 (USD Million)
  • TABLE 64 South Africa stem cells and non-stem cells market for clinical-use estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 65 South Africa stem cell and non-stem cell market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 66 South Africa stem cell therapies market for clinical-use estimates & forecasts, by cell-type, 2014 - 2025 (USD Million)
  • TABLE 67 South Africa stem cell & non stem cell market estimates & forecasts, by therapy type, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market summary
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain based sizing & forecasting
  • FIG. 7 QFD modelling for market share assessment
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Therapeutic delivery methods investigated in preclinical research in 2017, U.K.
  • FIG. 12 Some future key trends in regenerative medicine
  • FIG. 13 Market restraint relevance analysis (Current & future impact)
  • FIG. 14 Penetration & growth prospect mapping for Therapy, 2017
  • FIG. 15 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 16 Porter's Five Forces Analysis
  • FIG. 17 Stem cells & non-stem cells market: Use-type outlook key takeaways
  • FIG. 18 Global stem cells & non-stem cells market: Use-type movement analysis
  • FIG. 19 Global stem cells & non-stem cells market for clinical-use, 2014 - 2025 (USD Million)
  • FIG. 20 Global stem cell and non-stem cell market for malignancies market, 2014 - 2025 (USD Million)
  • FIG. 21 Global stem cell and non-stem cell market for muscoskeletal disorders, 2014 - 2025 (USD Million)
  • FIG. 22 Global stem cell and non-stem cell market for autoimmune disorders, 2014 - 2025 (USD Million)
  • FIG. 23 Global stem cell and non-stem cell market for dermatology, 2014 - 2025 (USD Million)
  • FIG. 24 Global stem cell and non-stem cell market for other therapeutic areas, 2014 - 2025 (USD Million)
  • FIG. 25 Global stem cell therapies market, 2014 - 2025 (USD Million)
  • FIG. 26 Global bone marrow, blood, & umbilical cord-derived stem cell therapies market, 2014 - 2025 (USD Million)
  • FIG. 27 Global adipose-derived stem cell therapies market, 2014 - 2025 (USD Million)
  • FIG. 28 Global other stem cell therapies market, 2014 - 2025 (USD Million)
  • FIG. 29 Global non-stem cell therapies market, 2014 - 2025 (USD Million)
  • FIG. 30 Global stem cells & non-stem cells market for research-use, 2014 - 2025 (USD Million)
  • FIG. 31 Stem cells & non-stem cells market: Therapy type outlook key takeaways
  • FIG. 32 Global stem cells & non-stem cells market: Therapy type movement analysis
  • FIG. 33 Global stem cells & non-stem cells market for allogenic therapies, 2014 - 2025 (USD Million)
  • FIG. 34 Global stem cells & non-stem cells market for autologous therapies, 2014 - 2025 (USD Million)
  • FIG. 35 Regional market place: Key takeaway
  • FIG. 36 Stem cells & non-stem cells regional outlook, 2017 & 2025
  • FIG. 37 North America cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 38 U.S. cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 39 Canada cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 40 Europe cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 41 Germany cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 42 U.K. cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 43 Asia Pacific cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 44 Japan cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 45 China cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 46 Latin America cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 47 Brazil cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 48 MEA cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 49 South Africa cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
  • FIG. 50 Strategy Framework
目次
Product Code: GVR-2-68038-701-8

The global cell therapy market size is expected to reach USD 7.92 billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 5.34% during the forecast period. Growing worldwide interest in discovering and development of advanced therapy medicinal products that are based on genes, tissues, or cells is likely to spur the growth of the market.

Companies and research communities are witnessed to invest heavily in isolation and culturing of a wide range of cell types, such as chondrocytes, keratinocytes, stem, cartilage, dermal papilla, and epithelial cells for development of cell therapies. Regulatory bodies are playing a crucial role in the growth of this market by enforcing new laws pertaining to product development and approval.

Moreover, U.S. FDA is engaged in keeping a check on practice of unauthorized therapies, which is also one of the major concerns in the market. Direct cell reprogramming is gaining attention as a novel therapeutic strategy owing to its efficacy and safety advantages. Fortuna Fix, a privately-held company, aimed at becoming the first company to bring in the clinical use of patient's own neural stem cells, produced by direct reprogramming for replacement of lost neuronal tissue in neurotrauma and neurodegeneration. Such ongoing activities in this space are anticipated to bolster the revenue generation in the future. Presence of scientific concerns pertaining to the usage of these therapies necessitates further studies for validation of clinical findings.

Further key findings from the report suggest:

  • Currently, there are less number of approved products for clinical use and withdrawal of several commercialized products. This has resulted in lesser share of the clinical usage segment in the market
  • The research use segment is projected to exhibit a CAGR of 5.6% during the forecast period. Presence of a substantial number of R&D projects is boosting investments in cell therapy for research use, thereby bolstering the growth of the segment
  • Based on therapy type, allogenic therapies will remain the most prominent segment throughout the forecast horizon. This is due to high price and large number of companies involved in development of allogenic therapies
  • On the other hand, autologous therapies are expected to post a higher CAGR during the same period. Lack of donors and affordability are two key drivers contributing to the growth of this segment

JCR Pharmaceuticals Co. Ltd.; Vericel Corporation; Osiris Therapeutics, Inc.; and MEDIPOST are some key players operating in the market. Companies are focusing in expanding their product portfolio and tapping into the potential of the market.

Table of Contents

Chapter 1: Executive Summary

  • 1.1 Market Snapshot

Chapter 2: Research Methodology

  • 2.1 Information Procurement
    • 2.1.1 Purchased Database
    • 2.1.2 GVR's Internal Database
  • 2.2 Data Analysis
  • 2.3 Market Formulation & Validation
  • 2.4 Approaches for Market Estimation
    • 2.4.1 Approach 1: Commodity Flow & Bottom Up Approach
    • 2.4.2 Approach 2: Top Down and Parent Market Analysis

Chapter 3: Market Variables, Trends, & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Rise in number of clinical studies pertaining to the development of cellular therapies
      • 3.1.1.2 Rising adoption of regenerative medicine
      • 3.1.1.3 Introduction of novel platforms and technologies
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Ethical concerns related to stem cell research
      • 3.1.2.2 Clinical issues pertaining to development & implementation of cell therapy
      • 3.1.2.2.1 Manufacturing issues
      • 3.1.2.2.2 Genetic instability
      • 3.1.2.2.3 Stem cell culture condition
      • 3.1.2.2.4 Stem cell distribution after transplant
      • 3.1.2.2.5 Immunological rejection
      • 3.1.2.2.6 Challenges associated with allogenic mode of transplantation
  • 3.2 Penetration & Growth Prospect Mapping For Therapy Type, 2017
  • 3.3 Stem Cells & Non-stem Cells Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4: Stem Cells & Non-stem Cells Market Categorization: Use-type Estimates & Trend Analysis

  • 4.1 Stem Cells & Non-stem Cells Market: Use-type Movement Analysis
  • 4.2 Clinical-use
    • 4.2.1 Stem cells & non-stem cells market for clinical-use, 2014 - 2025 (USD Million)
    • 4.2.2 Cell therapy market (stem cells & non-stem cells) for clinical-use, by therapeutic area
      • 4.2.2.1 Malignancies
      • 4.2.2.1.1 Stem cell and non-stem cell market for malignancies, 2014 - 2025 (USD Million)
      • 4.2.2.2 Muscoskeletal disorders
      • 4.2.2.2.1 Stem cell and non-stem cell market for muscoskeletal disorders, 2014 - 2025 (USD Million)
      • 4.2.2.3 Autoimmune disorders
      • 4.2.2.3.1 Stem cell and non-stem cell market for autoimmune disorders, 2014 - 2025 (USD Million)
      • 4.2.2.4 Dermatology
      • 4.2.2.4.1 Stem cell and non-stem cell market for dermatology, 2014 - 2025 (USD Million)
      • 4.2.2.5 Others
      • 4.2.2.5.1 Stem cell and non-stem cell market for other therapeutic areas, 2014 - 2025 (USD Million)
    • 4.2.3 Cell therapy market (stem cells & non-stem cells) for clinical-use, by cell type
      • 4.2.3.1 Stem cell therapies
      • 4.2.3.1.1 Stem cell therapies market, 2014 - 2025 (USD Million)
      • 4.2.3.1.2 Bone marrow, blood, & umbilical cord-derived stem cell therapies
      • 4.2.3.1.3 Adipose-derived stem cell therapies
      • 4.2.3.1.4 Other stem cell therapies
      • 4.2.3.2 Non-stem cell therapies
      • 4.2.3.2.1 Global non-stem cell therapies market, 2014 - 2025 (USD Million)
  • 4.3 Research-use
    • 4.3.1 Stem cells & non-stem cells market for research-use, 2014 - 2025 (USD Million)

Chapter 5: Stem Cells & Non-stem Cells Market Categorization: Therapy Type Estimates & Trend Analysis

  • 5.1 Stem Cells & Non-stem Cells Market: Therapy Type Movement Analysis
  • 5.2 Allogenic Therapies
    • 5.2.1 Global stem cells & non-stem cells market for allogenic therapies, 2014 - 2025 (USD Million)
  • 5.3 Autologous Therapies
    • 5.3.1 Global stem cells & non-stem cells market for autologous therapies, 2014 - 2025 (USD Million)

Chapter 6: Market Categorization: Regional Estimates & Trend Analysis, by Product

  • 6.1 Stem Cells & Non-stem Cells Market Share By Regional, 2017 & 2025
  • 6.2 North America
    • 6.2.1 Cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 Cell therapy market (stem cells & non-stem cells) , by use-type, 2014 - 2025 (USD Million)
      • 6.2.2.2 Cell therapy market (stem cells & non-stem cells) , by therapy type, 2014 - 2025 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Cell therapy market (stem cells & non-stem cells) , by use-type, 2014 - 2025 (USD Million)
      • 6.2.3.2 Cell therapy market (stem cells & non-stem cells) , by therapy type, 2014 - 2025 (USD Million)
  • 6.3 Europe
    • 6.3.1 Cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
    • 6.3.2 Germany
      • 6.3.2.1 Cell therapy market (stem cells & non-stem cells) , by use-type, 2014 - 2025 (USD Million)
      • 6.3.2.2 Cell therapy market (stem cells & non-stem cells) , by therapy type, 2014 - 2025 (USD Million)
    • 6.3.3 U.K.
      • 6.3.3.1 Cell therapy market (stem cells & non-stem cells) , by use-type, 2014 - 2025 (USD Million)
      • 6.3.3.2 Cell therapy market (stem cells & non-stem cells) , by therapy type, 2014 - 2025 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
    • 6.4.2 China
      • 6.4.2.1 Cell therapy market (stem cells & non-stem cells) , by use-type, 2014 - 2025 (USD Million)
      • 6.4.2.2 Cell therapy market (stem cells & non-stem cells) , by therapy type, 2014 - 2025 (USD Million)
    • 6.4.3 Japan
      • 6.4.3.1 Cell therapy market (stem cells & non-stem cells) , by use-type, 2014 - 2025 (USD Million)
      • 6.4.3.2 Cell therapy market (stem cells & non-stem cells) , by therapy type, 2014 - 2025 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Cell therapy market (stem cells & non-stem cells) , by use-type, 2014 - 2025 (USD Million)
      • 6.5.2.2 Cell therapy market (stem cells & non-stem cells) , by therapy type, 2014 - 2025 (USD Million)
  • 6.6 MEA
    • 6.6.1 Cell therapy market (stem cells & non-stem cells) , 2014 - 2025 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 Cell therapy market (stem cells & non-stem cells) , by use-type, 2014 - 2025 (USD Million)
      • 6.6.2.2 Cell therapy market (stem cells & non-stem cells) , by therapy type, 2014 - 2025 (USD Million)

Chapter 7: Competitive Landscape

  • 7.1 Strategy Framework
  • 7.2 Company Profiles
    • 7.2.1 Kolon TissueGene, Inc.
      • 7.2.1.1 Company overview
      • 7.2.1.2 Financial performance
      • 7.2.1.3 Product benchmarking
      • 7.2.1.4 Strategic initiatives
    • 7.2.2 JCR Pharmaceuticals Co., Ltd.
      • 7.2.2.1 Company overview
      • 7.2.2.2 Financial performance
      • 7.2.2.2.1 Financial performance of TEMCELL HS Inj
      • 7.2.2.3 Product benchmarking
      • 7.2.2.4 Strategic initiatives
    • 7.2.3 MEDIPOST
      • 7.2.3.1 Company overview
      • 7.2.3.2 Financial performance
      • 7.2.3.3 Product benchmarking
      • 7.2.3.4 Strategic initiatives
    • 7.2.4 Osiris Therapeutics, Inc.
      • 7.2.4.1 Company overview
      • 7.2.4.2 Financial performance
      • 7.2.4.3 Product benchmarking
      • 7.2.4.4 Strategic initiatives
    • 7.2.5 Stemedica Cell Technologies, Inc.
      • 7.2.5.1 Company overview
      • 7.2.5.2 Financial performance
      • 7.2.5.3 Product benchmarking
      • 7.2.5.4 Strategic initiatives
    • 7.2.6 Cells for Cells
      • 7.2.6.1 Company overview
      • 7.2.6.2 Financial performance
      • 7.2.6.3 Product benchmarking
      • 7.2.6.4 Strategic initiatives
    • 7.2.7 NuVasive, Inc
      • 7.2.7.1 Company overview
      • 7.2.7.2 Financial performance
      • 7.2.7.3 Product benchmarking
      • 7.2.7.4 Strategic initiatives
    • 7.2.8 Fibrocell Science, Inc.
      • 7.2.8.1 Company overview
      • 7.2.8.2 Financial performance
      • 7.2.8.3 Product benchmarking
      • 7.2.8.4 Strategic initiatives
    • 7.2.9 Vericel Corporation
      • 7.2.9.1 Company overview
      • 7.2.9.2 Financial performance
      • 7.2.9.3 Product benchmarking
      • 7.2.9.4 Strategic initiatives
    • 7.2.10 PHARMICELL Co., Ltd
      • 7.2.10.1 Company overview
      • 7.2.10.2 Financial performance
      • 7.2.10.3 Product benchmarking
      • 7.2.10.4 Strategic initiatives
    • 7.2.11 ANTEROGEN.CO.,LTD
      • 7.2.11.1 Company overview
      • 7.2.11.2 Financial performance
      • 7.2.11.3 Product benchmarking
      • 7.2.11.4 Strategic initiatives
    • 7.2.12 Celgene Corporation
      • 7.2.12.1 Company overview
      • 7.2.12.2 Financial performance
      • 7.2.12.3 Product benchmarking
      • 7.2.12.4 Strategic Initiatives
Back to Top